Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
XLO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XLO recently traded at $8.44. Market cap is $48.76M. P/E ratio is -1.97. Revenue is $43.77M.
| Metric | Value |
|---|---|
| Price | $8.44 |
| Market Cap | $48.76M |
| P/E Ratio | -1.97 |
| EPS | $-4.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.80 |
| 52-Week Low | $6.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $43.77M |
| Net Income | $-35.04M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $43.77M | $-35.04M | $-4.19 |
| 2024 | $6.34M | $-58.24M | $-1.09 |
| 2023 | $0 | $-76.40M | $-2.78 |
| 2022 | $0 | $-88.22M | $-3.22 |
XLO analyst coverage data. Average price target: $0.00.